Published in Drug Week, May 26th, 2006
"Thymosin beta10 is a cytoplasm G-actin sequestering protein whose functions are largely unknown. To determine the direct effects of exogenous thymosin beta10 on angiogenic potentials as endothelial cell migration and capillary-like tube formation, HCAECs were incubated with increasing doses of thymosin beta10 (25-100 ng/ml)," wrote H. Mu and colleagues, Baylor College of Medicine.
"By using a modified Boyden chamber assay, thymosin beta10 inhibited cell migration in a dose-...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.